Zhejiang Huahai Pharmaceutical Co., Ltd. Zhejiang Huahai Pharmaceutical Co., Ltd.

Zhejiang Huahai Pharmaceutical Co., Ltd.

600521

株式のランク #4356
Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical... Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical enterprise with a global presence. Its diverse portfolio encompasses treatments for central nervous system disorders, cardiovascular conditions, and viral infections, among other finished pharmaceutical products. Beyond finished drugs, the company also produces Active Pharmaceutical Ingredients (APIs) and crucial intermediates. Huahai Pharmaceutical further engages in the manufacturing of packaging components, notably high-density polyethylene (HDPE) bottles and polypropylene (PP) caps. Additionally, it offers contract manufacturing (CMO) and other specialized services, while also playing a role in import and export trade services. Established in 1989, the company maintains its headquarters in Linhai, China.
株価
$2.49
時価総額
$3.73B
変化(1日)
2.72%
変化(1年)
-7.38%
国
CN
取引 Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)

カテゴリー

Healthcare
Zhejiang Huahai Pharmaceutical Co., Ltd.(600521)のP/B比率
October 2026 時点のP/B比率 TTM: 2.51
Zhejiang Huahai Pharmaceutical Co., Ltd. の最新の財務報告および株価によると、現在のP/B比率(TTM)は 2.51 です。2023 年末時点でのP/B比率は 2.65 でした。
Zhejiang Huahai Pharmaceutical Co., Ltd. の P/B 比率の履歴(2000 ~ 2026)
各年末時点のP/B比率
年 P/B比率 変化
2026 (TTM) 2.51 -13.88%
2024 2.92 10.29%
2023 2.65 -36.78%
2022 4.19 -12.79%
2021 4.80 -36.36%
2020 7.54 85.37%
2019 4.07 32.50%
2018 3.07 -52.04%
2017 6.40 24.40%
2016 5.15 -7.28%
2015 5.55 57.53%
2014 3.52 4.58%
2013 3.37 6.18%
2012 3.17 -18.62%
2011 3.90 -27.34%
2010 5.37 -17.31%
2009 6.49 93.63%
2008 3.35 -49.89%
2007 6.69 83.20%
2006 3.65 42.68%
2005 2.56 -17.88%
2004 3.12 42.37%
2003 2.19 -88.84%
2002 19.61 -10.48%
2001 21.91 -10.48%
2000 24.48 0.00%